Frailty is independently associated with worse outcomes and increased resource utilization following endometrial cancer surgery.

Gynecologic Surgical Procedures Uterine Cancer

Journal

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
ISSN: 1525-1438
Titre abrégé: Int J Gynecol Cancer
Pays: England
ID NLM: 9111626

Informations de publication

Date de publication:
20 Jun 2022
Historique:
pmc-release: 20 12 2023
entrez: 20 6 2022
pubmed: 21 6 2022
medline: 21 6 2022
Statut: aheadofprint

Résumé

Frailty has been associated with poorer surgical outcomes and is a critical factor in procedural risk assessment. The objective of this study is to assess the impact of frailty on surgical outcomes in patients with endometrial cancer. Patients undergoing inpatient gynecologic surgery for endometrial cancer were identified using the 2005-2017 Nationwide Inpatient Sample database. The Johns Hopkins Adjusted Clinical Groups frailty-defining diagnosis indicator was used to designate frailty. Multivariate regression models were used to assess the association of frailty with postoperative outcomes and resource use. Of 339 846 patients, 2.9% (9868) were considered frail. After adjusting for patient and hospital characteristics, frailty was associated with a four-fold increase in inpatient mortality (adjusted OR (aOR) 4.1; p<0.001), non-home discharge (aOR 5.2; p<0.001), as well as increased respiratory (aOR 2.6; p<0.001), neurologic (aOR 3.3; p<0.001), renal (aOR 2.0; p<0.001), and infectious (aOR 3.2; p<0.001) complications. While frail patients exhibited increased mortality with age, the rate of mortality in this cohort decreased significantly over time. Compared with non-frail counterparts, frail patients had longer lengths of stay (7.6 vs 3.4 days; p<0.001) and increased hospitalization costs with surgical admission ($25 093 vs $13 405; p<0.001). Frailty is independently associated with worse surgical outcomes, including increased mortality and resource use, in women undergoing surgery for endometrial cancer. Though in recent years there have been improvements in mortality in the frail population, further efforts to mitigate the impact of frailty should be explored.

Identifiants

pubmed: 35725031
pii: ijgc-2022-003484
doi: 10.1136/ijgc-2022-003484
pmc: PMC9763544
mid: NIHMS1820863
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : T32 CA251072
Pays : United States

Informations de copyright

© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Clin Oncol. 2009 Jun 10;27(17):2758-65
pubmed: 19403886
Ann Oncol. 2013 Mar;24(3):843-50
pubmed: 23149571
Eur J Epidemiol. 2018 Aug;33(8):729-739
pubmed: 29779203
J Environ Public Health. 2017;2017:2819372
pubmed: 28408935
J Surg Oncol. 2020 Nov;122(6):1199-1206
pubmed: 32700323
J Natl Cancer Inst. 2021 Nov 29;113(12):1648-1669
pubmed: 34240195
CA Cancer J Clin. 2019 Nov;69(6):452-467
pubmed: 31390062
Geroscience. 2017 Apr;39(2):221-229
pubmed: 28281219
Physiol Behav. 2019 Apr 1;202:87-93
pubmed: 30726720
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28376154
Am J Public Health. 2004 Dec;94(12):2104-11
pubmed: 15569961
Clin Med (Lond). 2019 May;19(3):219-223
pubmed: 31092514
Surg Oncol. 2020 Mar;32:8-13
pubmed: 31683158
JAMA. 2017 Nov 28;318(20):2011-2018
pubmed: 29183077
JAMA Surg. 2021 Jan 1;156(1):e205152
pubmed: 33206156
Eur J Surg Oncol. 2021 Nov;47(11):2830-2840
pubmed: 34127328
Gynecol Oncol. 2015 Apr;137(1):98-101
pubmed: 25602715
Gynecol Oncol. 2020 Jul;158(1):130-136
pubmed: 32354470
Breast Cancer Res Treat. 2019 Oct;177(3):537-548
pubmed: 31270761
Am J Manag Care. 2012 Oct 01;18(10):e392-7
pubmed: 23145847
Ann Oncol. 2021 Aug;32(8):1025-1033
pubmed: 34022376
J Trauma Acute Care Surg. 2014 Apr;76(4):1151-6
pubmed: 24662884
Front Psychol. 2020 Mar 25;11:564
pubmed: 32273868
Gynecol Oncol. 2020 Nov;159(2):426-433
pubmed: 32868087
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Int J Gynecol Cancer. 2020 Dec;30(12):1893-1901
pubmed: 32847996
BMC Fam Pract. 2018 Oct 19;19(1):170
pubmed: 30340530
Gynecol Oncol. 2017 Jun;145(3):526-530
pubmed: 28359689
Int J Gynecol Cancer. 2018 Jan;28(1):19-25
pubmed: 28953134
JAMA Surg. 2020 Mar 1;155(3):233-242
pubmed: 31968063

Auteurs

Morcos Nakhla (M)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, USA.

Cortney M Eakin (CM)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, USA.

Ava Mandelbaum (A)

Cardiovascular Outcomes Research Laboratories (CORELAB), Division of Cardiac Surgery, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, USA.

Beth Karlan (B)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, USA.

Peyman Benharash (P)

Cardiovascular Outcomes Research Laboratories (CORELAB), Division of Cardiac Surgery, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, USA.

Ritu Salani (R)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, USA.

Joshua G Cohen (JG)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, USA cohen.g.joshua@gmail.com.

Classifications MeSH